INVESTIGATING THE IMPACT OF REPROGRAMMED PIK3R1-INSULIN-GLUCOSE METABOLISM PATHWAY IN LETHAL PROSTATE CANCER TO DEVELOP THERAPEUTIC STRATEGY
$505,270FY2025Defense Health AgencyDOD
Icahn School Of Medicine At Mount Sinai, New York NY
Icahn School Of Medicine At Mount Sinai, New York NY